Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma

A Consortium for Improving Survival of Lymphoma (CISL) report

Jina Yun, Seok Jin Kim, Jong Ho Won, Chul Won Choi, Hyeon Seok Eom, Jin Seok Kim, Min Kyoung Kim, Jae Yong Kwak, Won Seog Kim, Cheolwon Suh

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Fourteen patients had primary ovarian lymphoma, while eighteen patients had secondary ovarian involvement. There was no significant difference in survival rates between primary and secondary involvement with diffuse large B-cell lymphoma (DLBCL), the most common subtype. The 5-year overall survivals of primary and secondary involvement with DLBCL were 70.0% and 59.3%, respectively. The localized bilateral ovarian involvement showed poorer survival compared to stage III/IV patients with secondary ovarian involvement. Treatment outcomes of secondary ovarian involvement in non-Hodgkin's lymphoma were comparable to those of primary ovarian involvement, suggesting that ovarian involvement does not necessarily predict a worse prognosis for NHL patients.

Original languageEnglish
Pages (from-to)1175-1179
Number of pages5
JournalLeukemia Research
Volume34
Issue number9
DOIs
Publication statusPublished - 2010 Sep 1

Fingerprint

Non-Hodgkin's Lymphoma
Lymphoma
Survival
Lymphoma, Large B-Cell, Diffuse
Survival Rate

Keywords

  • B-cell
  • Chemotherapy
  • Lymphoma
  • Ovary
  • Prognosis
  • Rituximab
  • T-cell

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma : A Consortium for Improving Survival of Lymphoma (CISL) report. / Yun, Jina; Kim, Seok Jin; Won, Jong Ho; Choi, Chul Won; Eom, Hyeon Seok; Kim, Jin Seok; Kim, Min Kyoung; Kwak, Jae Yong; Kim, Won Seog; Suh, Cheolwon.

In: Leukemia Research, Vol. 34, No. 9, 01.09.2010, p. 1175-1179.

Research output: Contribution to journalArticle

Yun, Jina ; Kim, Seok Jin ; Won, Jong Ho ; Choi, Chul Won ; Eom, Hyeon Seok ; Kim, Jin Seok ; Kim, Min Kyoung ; Kwak, Jae Yong ; Kim, Won Seog ; Suh, Cheolwon. / Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma : A Consortium for Improving Survival of Lymphoma (CISL) report. In: Leukemia Research. 2010 ; Vol. 34, No. 9. pp. 1175-1179.
@article{7795d09ad51b45759ad945c5aa907e44,
title = "Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report",
abstract = "Fourteen patients had primary ovarian lymphoma, while eighteen patients had secondary ovarian involvement. There was no significant difference in survival rates between primary and secondary involvement with diffuse large B-cell lymphoma (DLBCL), the most common subtype. The 5-year overall survivals of primary and secondary involvement with DLBCL were 70.0{\%} and 59.3{\%}, respectively. The localized bilateral ovarian involvement showed poorer survival compared to stage III/IV patients with secondary ovarian involvement. Treatment outcomes of secondary ovarian involvement in non-Hodgkin's lymphoma were comparable to those of primary ovarian involvement, suggesting that ovarian involvement does not necessarily predict a worse prognosis for NHL patients.",
keywords = "B-cell, Chemotherapy, Lymphoma, Ovary, Prognosis, Rituximab, T-cell",
author = "Jina Yun and Kim, {Seok Jin} and Won, {Jong Ho} and Choi, {Chul Won} and Eom, {Hyeon Seok} and Kim, {Jin Seok} and Kim, {Min Kyoung} and Kwak, {Jae Yong} and Kim, {Won Seog} and Cheolwon Suh",
year = "2010",
month = "9",
day = "1",
doi = "10.1016/j.leukres.2010.02.010",
language = "English",
volume = "34",
pages = "1175--1179",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma

T2 - A Consortium for Improving Survival of Lymphoma (CISL) report

AU - Yun, Jina

AU - Kim, Seok Jin

AU - Won, Jong Ho

AU - Choi, Chul Won

AU - Eom, Hyeon Seok

AU - Kim, Jin Seok

AU - Kim, Min Kyoung

AU - Kwak, Jae Yong

AU - Kim, Won Seog

AU - Suh, Cheolwon

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Fourteen patients had primary ovarian lymphoma, while eighteen patients had secondary ovarian involvement. There was no significant difference in survival rates between primary and secondary involvement with diffuse large B-cell lymphoma (DLBCL), the most common subtype. The 5-year overall survivals of primary and secondary involvement with DLBCL were 70.0% and 59.3%, respectively. The localized bilateral ovarian involvement showed poorer survival compared to stage III/IV patients with secondary ovarian involvement. Treatment outcomes of secondary ovarian involvement in non-Hodgkin's lymphoma were comparable to those of primary ovarian involvement, suggesting that ovarian involvement does not necessarily predict a worse prognosis for NHL patients.

AB - Fourteen patients had primary ovarian lymphoma, while eighteen patients had secondary ovarian involvement. There was no significant difference in survival rates between primary and secondary involvement with diffuse large B-cell lymphoma (DLBCL), the most common subtype. The 5-year overall survivals of primary and secondary involvement with DLBCL were 70.0% and 59.3%, respectively. The localized bilateral ovarian involvement showed poorer survival compared to stage III/IV patients with secondary ovarian involvement. Treatment outcomes of secondary ovarian involvement in non-Hodgkin's lymphoma were comparable to those of primary ovarian involvement, suggesting that ovarian involvement does not necessarily predict a worse prognosis for NHL patients.

KW - B-cell

KW - Chemotherapy

KW - Lymphoma

KW - Ovary

KW - Prognosis

KW - Rituximab

KW - T-cell

UR - http://www.scopus.com/inward/record.url?scp=77955281346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955281346&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2010.02.010

DO - 10.1016/j.leukres.2010.02.010

M3 - Article

VL - 34

SP - 1175

EP - 1179

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 9

ER -